Japan’s GPIF posts $33.3 bln Q2 loss as global bond selloff hits foreign holdings

More in Finance

• Why is Halozyme Therapeutics stock sliding today?

  Shares of the biotechnology company are facing negative momentum during active trading as market participants evaluate current movements. The equity experienced an immediate downward trajectory, marking a retreat from its previous price levels. Observers are tracking the shift closely as the company navigates this downward pressure in the financial market.

  1 min read
• Why is Affirm stock sliding today?

  Market participants are observing downward movement in shares of the financial technology company during the current session. The sudden retreat has drawn attention across the exchange as investors track the performance of the payments firm. Further information regarding the precise causes behind the decline is still emerging.

  1 min read
• Why is Guardant Health stock sliding today?

  Shares of the precision oncology company are facing downward pressure as investors react to ongoing trading momentum. The movement reflects an immediate shift in market sentiment surrounding the equity during the current session. Stakeholders are closely monitoring the decline to determine whether broader sector trends or internal factors are driving the sell-off.

  1 min read